From the video - They were initially basing their decision on treatment on CCR5 on the tumor cells, then changed over to CCR5 levels in monocytes surrounding the tumor. That may give us patients with the highest level of response rate, but from other research highly elevated CCR5 against baseline throughout the body would be as useful.